International pharmaceutical companies [should] not only look at Japan as a single country, but also as the gateway to Asia
In Conversation
Regulatory intervention in India is more rigorous than ever before
India's thriving ecosystem, coupled with the increasing demand for the right partners and investments, makes it an ideal destination for those looking to be part of…
In terms of innovation, the [Indian pharmaceutical] landscape is evolving, but not at a pace that matches global leaders
Practice venturing into areas that make you uncomfortable; these are the assignments that give us maximum learning and personal growth. If you have the aspiration, raise…
Our focus revolves around three key aspects: API, international formulation exports, and the domestic market... targeting a compounded annual growth rate of 25 to 30 percent…
We are steadily transforming from a relatively smaller player in generics and early-phase clinical studies to a broader and more relevant Contract Research Organization for our…
Over the next three years, our focus is set on three fundamental elements to drive growth and impact: portfolio transformation, capability building, and expanding the HCP…
Our collective journey to build a leading international dermatology company in India has just begun, and I am confident that with the dedication, passion, and unwavering…
Our aspirations are ambitious, aiming for a three-fold increase in size over the next 8-10 years
We have the experience, the footprint, the governance, and the ambition to leverage the opportunities ahead and forge a new path for pharmaceuticals in Gujarat
We actively sought out synergies in the diagnostic business and view partnerships as a means to avoid reinventing the wheel
